Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry

Dai, Yan; Yang, Jingang; Gao, Zhan; Sun, Yi; Wu, Yuan; Gao, Xiaojin; Li, Wei; Wang, Yang; Gao, Runlin; Yang, Yue-Jin

doi:10.1186/s12872-016-0442-9

Cited by 22 publications

(31 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, such a ‘triple therapy’ strategy poses risks for bleeding and OACs are globally underused in clinical practice 14–19. The China acute myocardial infarction (CAMI) registry found that from 2013 to 2014, only 5.1% of patients with ACS and AF were treated using warfarin, and 1.7% were treated using both warfarin and DAPT 25. No NOACs were prescribed in patients with ACS and AF in the CAMI study.…”

Section: Discussionmentioning

confidence: 99%

A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation

Mai

Luo

et al. 2019

BMJ Open

View full text Add to dashboard Cite

ObjectiveTo examine the real-world patterns of oral anticoagulant (OAC) therapy in patients with acute coronary syndrome (ACS) and atrial fibrillation (AF) in Southern China undergoing percutaneous coronary intervention (PCI) and determine the clinical characteristics associated with OAC prescription.DesignA retrospective cohort study.SettingThis study was conducted in the Shunde Hospital, Southern Medical University and the second hospital of Zhaoqing, China, from January 2013 to 31 December 2018.ParticipantsPatients were aged ≥18 years, hospitalised for ACS and received PCI treatment.Outcome measuresAF was diagnosed based on an ECG recording or a Holter monitor. Prescription of OACs and antiplatelets were determined from the discharge medication list.ResultsA total of 3612 patients with ACS were included: 286 (7.9%) were diagnosed with AF, including 45 (1.2%) with paroxysmal AF, 227 (6.3%) with persistent/permanent AF and 14 (0.4%) with unclassified AF. Although 95.5% of patients with AF were at high risk (CHA2DS2-VASc score ≥2) of stroke, only 21.7% of them were discharged on OACs (10.5% received warfarin and 11.2% received non-vitamin K antagonist OACs). Patients with pre-admission use of OAC, a HAS-BLED score <3, with persistent/permanent AF were more likely to receive OAC treatment at discharge.ConclusionWe found that approximately 8% of patients who underwent PCI during ACS hospitalisation also demonstrated AF. Anticoagulant therapy was greatly underused. Patients with paroxysmal AF and an increased risk of bleeding were less likely to receive anticoagulant treatment. Further efforts should be made to increase the adherence to guideline recommendations for OACs.

show abstract

Section: Discussionmentioning

confidence: 99%

A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation

Mai

Luo

et al. 2019

BMJ Open

View full text Add to dashboard Cite

show abstract

“…Approximately 75% of these lesions are benign tumors, such as myxomas, rhabdomyomas, lipomas, fibromas, and teratomas [ 3 – 5 ]. Lipomas represent approximately 10% of all primary cardiac tumors [ 4 – 9 ]. Additionally, about 25% of cardiac lipomas are intramyocardial, 25% are extracavitary with an epicardial origin, and 50% are intracavitary with a subendocardial origin [ 4 , 10 , 11 ].…”

Section: Introductionmentioning

confidence: 99%

“…Lipomas represent approximately 10% of all primary cardiac tumors [ 4 – 9 ]. Additionally, about 25% of cardiac lipomas are intramyocardial, 25% are extracavitary with an epicardial origin, and 50% are intracavitary with a subendocardial origin [ 4 , 10 , 11 ]. They usually appear on the walls of the right atrium or left ventricle [ 4 , 8 , 11 , 12 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Voluminous Intrapericardial Lipoma Mimicking Pericardial Effusion

Morais

Nakajima

Andalécio

et al. 2020

Case Reports in Medicine

View full text Add to dashboard Cite

Lipomas are rare primary heart tumors and may involve the endocardium, myocardium, or pericardium. Signs and symptoms depend on the tumor location and size. The intrapericardial lipoma we report has massive dimensions and mimics a pericardial effusion. A 38-year-old male complained of dyspnea and precordial pain. On physical examination, heart sounds were diminished. The patient had received extensive medication for a clinically suspected pericardial effusion due to heart failure. A voluminous mass resembling fat within the pericardial sac was revealed by transesophageal echocardiography and a computed tomography scan. The tumor was removed successfully by a subxiphoid surgical approach. The diagnosis of a 635 gram intrapericardial lipoma was confirmed by pathological examination. After surgery, the patient recovered well and was completely asymptomatic at a follow-up at 90 days. No medications were being taken since. The diagnosis of a pericardial effusion should be secured by imaging exams to avoid unnecessary medications. Cardiac lipomas can be readily recognized by their typical features on radiologic imaging. The surgical pathology examination confirms the diagnosis and rules out malignancy criteria.

show abstract

“…The China Acute Myocardial Infarction registry showed that the overall incidence of atrial fibrillation was 3.0% in Chinese patients with acute myocardial infarction during hospitalization. 27 This study demonstrated an even higher presence of atrial fibrillation in patients with PoMCE. The CHADS2-VASc is able to predict mortality in patients with atrial fibrillation undergoing noncardiac surgery.…”

Section: Discussionmentioning

confidence: 53%

Clinical utility of the revised cardiac risk index in older Chinese patients with known coronary artery disease

Che¹,

Xu²,

Huang³

et al. 2017

CIA

View full text Add to dashboard Cite

ObjectivesThe revised Cardiac Risk Index (RCRI) is the most widely used risk prediction tool for postoperative cardiac adverse events. We aim to explore the predictive ability of the RCRI in older Chinese patients with coronary artery disease (CAD) undergoing noncardiac surgery, which has not been previously evaluated.MethodsWe performed a multicenter, prospective study. We enrolled a total of 1,202 patients, aged >60 years, with a history of CAD who underwent noncardiac surgery. Perioperative data were extracted from an electronic database. The primary end point was defined as an occurrence of a postoperative major cardiac event (PoMCE) within 30 days. Logistic regression analysis was performed to evaluate the performance of the RCRI. A modified RCRI was created and compared with the original RCRI with regard to its ability to predict postoperative cardiac events.ResultsOf the enrolled patients, 4.3% experienced PoMCE. Most components of the RCRI were not predictive of postoperative cardiac events with the exception of insulin-dependent diabetes mellitus (odds ratio =2.38, 95% CI: 1.11–5.11; P=0.03). The RCRI performed no better than chance (area under the curve =0.53; 95% CI: 0.45–0.61) in identifying patients’ cardiac risk. The modified score had a higher discriminatory ability toward PoMCE (c index, 0.69 versus 0.53; P<0.01).ConclusionThe original RCRI shows poor predictive ability in Chinese patients with CAD undergoing noncardiac surgery.

show abstract

Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry

Cited by 22 publications

References 37 publications

A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation

A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation

Voluminous Intrapericardial Lipoma Mimicking Pericardial Effusion

Clinical utility of the revised cardiac risk index in older Chinese patients with known coronary artery disease

Contact Info

Product

Resources

About